XGN
EXAGEN INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$7.43
−3.76%Leverage
- Debt / equity
- 2.09x
- Net debt / equity
- 0.08x
- Debt / assets
- 0.49x
- Debt / EBITDA
- -2.26x
- Net debt / EBITDA
- -0.08x
Liquidity & coverage
- Current ratio
- 3.18x
- Quick ratio
- 3.18x
- Cash ratio
- 1.83x
- Interest coverage
- -2.58x
- EBITDA / interest
- -2.21x
- Working capital
- $29.4M
Cash & dividend
- FCF / debt
- -0.30x
- Cash flow / debt
- -0.25x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026